High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation-Reference-Cited by-同舟云学术

High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation

Published:2019 Issue:1 Volume:59 Page:1-16
ISSN:1346-4280
Container-title:Journal of Clinical and Experimental Hematopathology
language:en
Short-container-title:J Clin Exp Hematopathol

Author:

Carreras Joaquim,Lopez-Guillermo Armando,Kikuti Yara Yukie,Itoh Johbu,Masashi Miyaoka,Ikoma Haruka,Tomita Sakura,Hiraiwa Shinichiro,Hamoudi Rifat,Rosenwald Andreas,Leich Ellen,Martinez Antonio,Roncador Giovanna,Villamor Neus,Colomo Lluis,Perez Patricia,Tsuji Noriko M,Campo Elias,Nakamura Naoya

Publisher

Japanese Society for Lymphoreticular Tissue Research

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslrt/59/1/59_19003/_pdf

Reference44 articles.

1. 1 Carreras J, Lopez-Guillermo A, Fox BC et al. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood. 2006; 108: 2957-2964.

2. 2 Martinez A, Carreras J, Campo E. The follicular lymphoma microenvironment: from tumor cell to host immunity. Curr Hematol Malig Rep. 2008; 3: 179-186.

3. 3 Carreras J, Lopez-Guillermo A, Roncador G et al. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol. 2009; 27: 1470-1476.

4. 4 Solal-Céligny P, Roy P, Colombat P et al. Follicular lymphoma international prognostic index. Blood. 2004; 104: 1258-1265.

5. 5 Zhou J, Mauerer K, Farina L, Gribben JG. The role of the tumor microenvironment in hematological malignancies and implication for therapy. Front Biosci. 2005; 10: 1581-1596.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function;Cellular Oncology;2024-05-29

2. The role of the BTLA–HVEM complex in the pathogenesis of breast cancer;Breast Cancer;2024-03-14

3. The BTLA-HVEM complex – The future of cancer immunotherapy;European Journal of Medicinal Chemistry;2024-03

4. BTLA biology in cancer: from bench discoveries to clinical potentials;Biomarker Research;2024-01-17

5. Expression and Clinical Significance of Tfh Cells and IL-21, IFN-<i>γ</i><i> </i>Secreted by It in Chronic Lymphocytic Leukemia;Advances in Clinical Medicine;2024